Navigation Links
China Medical Technologies Announces Plan of Senior Notes Offering

China Medical Technologies Announces Plan of Senior Notes Offering -- BEIJING, Sept. 21 /PRNewswire-Asia-FirstCall/ --

Advanced Search Search

  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, Pharmaceuticals, Stock Offering Click to view news release full screen  

China Medical Technologies Announces Plan of Senior Notes Offering


BEIJING, Sept. 21 /PRNewswire-Asia-FirstCall/ -- China Medical Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based advanced in-vitro diagnostic ("IVD") company, today announced that it plans to offer, subject to market and other conditions, up to US$200 million aggregate principal amount of senior notes (the "Notes") with a maturity of five years in a private offering that is exempt from the registration requirements of the U.S. Securities Act of 1933, as amended (the "Securities Act"). The Company intends to use the net proceeds from this private offering to repurchase, redeem or repay its convertible notes. The final terms of the Notes will be determined at the time of pricing of the Notes.

The Notes will be offered and sold only to qualified institutional buyers in reliance on Rule 144A and in offshore transactions pursuant to Regulation S under the Securities Act. The Notes have not been and will not be registered under the Securities Act or any state securities laws of the United States or under applicable laws of any other jurisdictions and may not be offered or sold in the United States absent an effective registration statement or an applicable exemption from registration requirements or a transaction not subject to the registration requirements of the Securities Act or any state securities laws or in other jurisdictions unless offered or sold in compliance with their applicable laws. This release shall not constitute an offer to sell or the solicitation of an offer to buy any of the Notes, nor shall it constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful.

About China Medical Technologies, Inc.

China Medical Technologies, Inc. is a leading China-based advanced IVD company using molecular diagnostic technologies including Fluorescent in situ Hybridization (FISH) and Surface Plasmon Resonance (SPR) and an immunodiagnostic technology, Enhanced Chemiluminescence Immunoassay (ECLIA), to develop, manufacture and distribute diagnostic products used for the detection of various cancers, diseases and disorders as well as companion diagnostic tests for targeted cancer drugs. The Company generates all of its revenues in China through the sale of diagnostic consumables including FISH probes, SPR-based DNA chips and ECLIA reagent kits to hospitals which are recurring users of the consumables for their patients. The Company sells FISH probes and SPR chips to large hospitals through its direct sales force and ECLIA reagent kits to small and mid-size hospitals through distributors. For more information, please visit .

Safe Harbor Statement

This press release contains forward-looking statements. These statements constitute "forward-looking" statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Examples of such statements in this press release include, among other matters, the pricing and the completion of the proposed offering of the Notes and the intended use of proceeds. Many of the factors that will determine the outcome of the subject matter of this press release are beyond the Company's ability to control or predict. The Company does not undertake any obligation to update any forward-looking statement as a result of new information, future events or otherwise, except as required under applicable law.

For more information, please contact: Sam Tsang and Winnie Yam Tel: +852-2511-9808 Email:

SOURCE China Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Special Event Providing Exclusive Access to Shanghais Booming Zhangjiang Pharma Valley Added to Agenda of First Annual SBS China Conference
2. China-Biotics Files New Patent Applications
3. China Cord Blood Corporation Announces Mandate for Share Repurchase Program
4. China Cord Blood Corporation Announces Framework Agreement Regarding Fourth License - Zhejiang Province
5. Reportlinker Adds Healthcare IT Market Outlook in China to 2016 - Hospital Information Systems and Medical Imaging Information Systems
6. China-Biotics, Inc. Comments on Market Rumors
7. Reportlinker Adds Clinical Trials in China
8. EntreMed Secures $5.1 Million in Registered Direct Offering and Enters into Agreement for Rights to License ENMD-2076 in China
9. China PharmaHub Corp. Begins Trading Under Stock Symbol CPHB Instead of WRLC
10. China Sky One Medical Updates Financial Guidance for 2010
11. China-Biotics Announces September 20 Investor Day Schedule
Post Your Comments:
(Date:10/8/2015)... , Oct. 8, 2015  "They really did ... of her Kaiser Permanente care team, after a routine ... treatment plan for cancer. The 79-year-old Kaiser Permanente Senior ... , went in for what she thought was tendinitis ... physician and care team, however, she was diagnosed with ...
(Date:10/8/2015)...  Trovagene, Inc., (NASDAQ:   TROV) a developer ... of results from a field experience analysis featuring ... (PCM) platform to accurately identify mutational status, ... appropriate therapy for patients. Mark Erlander , ... the results today in an oral presentation titled ...
(Date:10/8/2015)... York , October 8, 2015 ... Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022 ... valued at USD 2.63 billion in 2013 and is anticipated ... 2022 to reach USD 4.00 billion in 2022. --> ... Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - ...
Breaking Medicine Technology:
... Calif., May 17, 2012   Accuray Incorporated (Nasdaq: ... announced today the appointment of Richard Pettingill, LFACHE as ... May 11, 2012.   Richard Pettingill,s career ... leadership positions in a variety of prominent organizations. Most ...
... 2012 Simbionix USA Corporation, the ... education products, is proud to announce the release ... GI Mentor™ Express simulator and the ...      (Logo: ...
Cached Medicine Technology:
(Date:10/9/2015)... , ... October 09, 2015 , ... ... their “Agents of Change” program, a community improvement initiative that involves working with ... to benefit from the assistance of Confidence Plus Insurance is the Gleason Park ...
(Date:10/9/2015)... (PRWEB) , ... October 09, 2015 , ... ... States, is welcoming individuals from all walks of life to save money on ... set price of $25 per month per medication, individuals and families can receive ...
(Date:10/9/2015)... Nashville, TN (PRWEB) , ... October 09, 2015 , ... ... to announce their partnership as MD Anderson prepares to go-live on the Epic platform ... effort planned for early 2016. Santa Rosa will execute the contract by supporting Scheduling ...
(Date:10/9/2015)... Maryland (PRWEB) , ... October 09, 2015 , ... ... and assisted living placement counseling, recently opened its newest office in Maryland – ... senior care industry with a background as a project management technology consultant to ...
(Date:10/9/2015)... ... October 09, 2015 , ... BrightStar ... recognized by Cabarrus County Active Living and Parks for its outstanding commitment to ... company’s dedication to consistently going above and beyond the call of duty, seniors ...
Breaking Medicine News(10 mins):
... for those with scent-robbing viral infection, study found , ... people who lose their sense of smell after a ... 15 patients with post-viral olfactory dysfunction (PVOD) had 10 ... were compared with PVOD patients treated with vitamin B ...
... activity in depressed and anxious people indicates that some of ... or for worse by anxiety. The study, in ... at depression and two types of anxiety: anxious arousal, the ... better known as worry. The researchers used functional Magnetic ...
... Damaka ... platforms , ... TX (PRWEB) April 1, 2010 -- Damaka, a technology pioneer in Mobile Unified ... 2-way Video, Application Sharing) Sweeping™ between laptops and mobile devices earlier in May 2009. ...
... ... Town Plaque of Honor for Excellence in Customer Satisfaction for the second year in a row. ... local business based on customer reviews found on the Internet’s most respected user review websites. ... Minneapolis, MN (PRWEB) April 1, ...
... first study of its kind, 161 postnatal women with ... groups to test the effect of a physiotherapist-led exercise ... group received an eight-week "Mother and Baby" program, including ... with parenting education. In the second group, ...
... at the University of Delaware have developed a new ... Alzheimer,s, and other diseases., Developed by Zhihao Zhuang, UD ... group, the chemical method yields hundredsfold more ubiquitylated proteins ... to revealing such mysteries as how cancer cells gain ...
Cached Medicine News:
... ideal where space is restricted. Due to ... and flexible in every situation. For many ... be positioned optimally on the JUPITER during ... the operating theatre, the high level of ...
... schaerer axis 800 operating ... designed for those disciplines ... access. The stability, the ... the offset positioned telescoping ...
... words "mobile operating table" literally! The Alphastar 1132 ... of a general purpose operating table - is ... operations, a cable connected hand control, an IR-hand ... there is a control panel at the top ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
Medicine Products: